In VivoGlen Clova Scientific is a biotech startup taking a novel approach to treating chronic conditions, with a focus on debilitating skin and immune disorders. Founded in 2022 by dermatologist John Foerste
ScripThe amyotrophic lateral sclerosis (ALS) pipeline has suffered a series of setbacks recently and two separate candidates from AbbVie/Calico Life Sciences and Denali Therapeutics that have the same of m
Scrip2024 got off to a good start for Vertex with positive Phase III studies of its novel pain therapy, suzetrigine (then known as VX-548), reported in January. The non-opioid, oral selective inhibitor of
In VivoAs the pharmaceutical sector continues to evolve, the landscape of sales-driving indications is set to undergo transformation by 2030. In this article In Vivo delves into the therapeutic areas poise